ArticleNutrition & metabolism2026
Trends and disparities in glycemic control and severe hyperglycemia in U.S. adults with diabetes mellitus before and during COVID-19 pandemic.
Article in Nutrition & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe COVID-19 pandemic disrupted healthcare delivery and individual behaviors in individuals with diabetes. Limited data exist on glycemic control during this period. This study aimed to evaluate trends in glycemic control and severe hyperglycemia among U.S. adults with diagnosed diabetes before and during the COVID-19 pandemic.
methodsWe conducted a retrospective cohort analysis of data from the National Health and Nutrition Examination Survey (NHANES) between pre-pandemic (January 2017-March 2020) and pandemic (August 2021-August 2023) periods. Glycemic control (HbA1c < 7%) and severe hyperglycemia (HbA1c > 10%) were assessed overall and by age, race/ethnicity, and socioeconomic status using logistic regression.
resultsAmong 2528 adults with diabetes, glycemic control remained unchanged between pre- and during the pandemic (59.7% vs. 56.1%, p = 0.29), but severe hyperglycemia increased significantly (5.6% to 8.5%, p = 0.03). Female participants were more likely to achieve glycemic control (adjusted OR [aOR], 1.40; 95% CI, 1.11-1.75), and those with more than high school education had higher glycemic control (aOR, 1.33; 95% CI, 1.06-1.67) and lower severe hyperglycemia (aOR, 0.51; 95% CI, 0.29-0.89). Severe hyperglycemia was least prevalent in adults aged 65 years or older (aOR, 0.27; 95% CI, 0.15-0.50) but more common among Hispanic/Mexican American (aOR, 2.62; 95% CI, 1.53-4.50) and Non-Hispanic Black adults (aOR, 2.80; 95% CI, 1.62-4.84).
conclusionWhile glycemic control remained stable, severe hyperglycemia increased during the COVID-19 pandemic, particularly among Hispanic/Mexican American and Non-Hispanic Black adults. Higher education and older age were associated with better outcomes, emphasizing the need for targeted interventions to address disparities and prevent hyperglycemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.